413 related articles for article (PubMed ID: 9825482)
21. Apoptosis-induction and phosphorylation state in human pancreatic carcinoma xenografts following octreotide treatment.
Zalatnai A; Pogány V
Anticancer Res; 2001; 21(1A):477-80. PubMed ID: 11299782
[TBL] [Abstract][Full Text] [Related]
22. Crucial role for somatostatin receptor subtype 2 in determining the uptake of [111In-DTPA-D-Phe1]octreotide in somatostatin receptor-positive organs.
Hofland LJ; Lamberts SW; van Hagen PM; Reubi JC; Schaeffer J; Waaijers M; van Koetsveld PM; Srinivasan A; Krenning EP; Breeman WA
J Nucl Med; 2003 Aug; 44(8):1315-21. PubMed ID: 12902423
[TBL] [Abstract][Full Text] [Related]
23. Effects of combined octreotide and aspirin on the growth of gastric cancer.
Tang C; Wang C; Tang L
Chin Med J (Engl); 2003 Mar; 116(3):373-7. PubMed ID: 12781040
[TBL] [Abstract][Full Text] [Related]
24. CEP-7055: a novel, orally active pan inhibitor of vascular endothelial growth factor receptor tyrosine kinases with potent antiangiogenic activity and antitumor efficacy in preclinical models.
Ruggeri B; Singh J; Gingrich D; Angeles T; Albom M; Yang S; Chang H; Robinson C; Hunter K; Dobrzanski P; Jones-Bolin S; Pritchard S; Aimone L; Klein-Szanto A; Herbert JM; Bono F; Schaeffer P; Casellas P; Bourie B; Pili R; Isaacs J; Ator M; Hudkins R; Vaught J; Mallamo J; Dionne C
Cancer Res; 2003 Sep; 63(18):5978-91. PubMed ID: 14522925
[TBL] [Abstract][Full Text] [Related]
25. GI hormonal changes in diabetes influence pancreatic cancer growth.
Fisher WE; Boros LG; O'Dorisio TM; O'Dorisio MS; Schirmer WJ
J Surg Res; 1995 Jun; 58(6):754-8. PubMed ID: 7791356
[TBL] [Abstract][Full Text] [Related]
26. Effect of somatostatin and octreotide on proliferation and vascular endothelial growth factor secretion from murine endothelial cell line (HECa10) culture.
Lawnicka H; Stepień H; Wyczółkowska J; Kolago B; Kunert-Radek J; Komorowski J
Biochem Biophys Res Commun; 2000 Feb; 268(2):567-71. PubMed ID: 10679244
[TBL] [Abstract][Full Text] [Related]
27. Effect of treatment with depot somatostatin analogue octreotide on primary hyperparathyroidism (PHP) in multiple endocrine neoplasia type 1 (MEN1) patients.
Faggiano A; Tavares LB; Tauchmanova L; Milone F; Mansueto G; Ramundo V; De Caro ML; Lombardi G; De Rosa G; Colao A
Clin Endocrinol (Oxf); 2008 Nov; 69(5):756-62. PubMed ID: 18485119
[TBL] [Abstract][Full Text] [Related]
28. The neurotrophin-trk receptor axes are critical for the growth and progression of human prostatic carcinoma and pancreatic ductal adenocarcinoma xenografts in nude mice.
Miknyoczki SJ; Wan W; Chang H; Dobrzanski P; Ruggeri BA; Dionne CA; Buchkovich K
Clin Cancer Res; 2002 Jun; 8(6):1924-31. PubMed ID: 12060637
[TBL] [Abstract][Full Text] [Related]
29. Identification of somatostatin receptor subtypes and an implication for the efficacy of somatostatin analogue SMS 201-995 in treatment of human endocrine tumors.
Kubota A; Yamada Y; Kagimoto S; Shimatsu A; Imamura M; Tsuda K; Imura H; Seino S; Seino Y
J Clin Invest; 1994 Mar; 93(3):1321-5. PubMed ID: 8132773
[TBL] [Abstract][Full Text] [Related]
30. Multiply radioiodinated somatostatin analogs induce receptor-specific cytotoxicity.
Meyers MO; Anthony CT; Coy DH; Murphy WA; Drouant GJ; Fuselier J; Espenan GD; Maloney TJ; Woltering EA
J Surg Res; 1998 May; 76(2):154-8. PubMed ID: 9698516
[TBL] [Abstract][Full Text] [Related]
31. Enhanced survival in perineural invasion of pancreatic cancer: an in vitro approach.
Dai H; Li R; Wheeler T; Ozen M; Ittmann M; Anderson M; Wang Y; Rowley D; Younes M; Ayala GE
Hum Pathol; 2007 Feb; 38(2):299-307. PubMed ID: 17097719
[TBL] [Abstract][Full Text] [Related]
32. Characterization of cloned human somatostatin receptor SSTR5.
O'Carroll AM; Raynor K; Lolait SJ; Reisine T
Mol Pharmacol; 1994 Aug; 46(2):291-8. PubMed ID: 8078491
[TBL] [Abstract][Full Text] [Related]
33. Quantitative and functional expression of somatostatin receptor subtypes in human thymocytes.
Ferone D; Pivonello R; Van Hagen PM; Dalm VA; Lichtenauer-Kaligis EG; Waaijers M; Van Koetsveld PM; Mooy DM; Colao A; Minuto F; Lamberts SW; Hofland LJ
Am J Physiol Endocrinol Metab; 2002 Nov; 283(5):E1056-66. PubMed ID: 12376335
[TBL] [Abstract][Full Text] [Related]
34. Detection of somatostatin receptors in surgical and percutaneous needle biopsy samples of carcinoids and islet cell carcinomas.
Reubi JC; Kvols LK; Waser B; Nagorney DM; Heitz PU; Charboneau JW; Reading CC; Moertel C
Cancer Res; 1990 Sep; 50(18):5969-77. PubMed ID: 2168286
[TBL] [Abstract][Full Text] [Related]
35. Somatostatin analog inhibits the growth of insulinoma cells by p27-mediated G1 cell cycle arrest.
Aoki T; Motoi F; Sakata N; Naitoh T; Katayose Y; Egawa S; Miyazaki J; Unno M
Pancreas; 2014 Jul; 43(5):720-9. PubMed ID: 24694834
[TBL] [Abstract][Full Text] [Related]
36. Cytotoxic analog of somatostatin containing methotrexate inhibits growth of MIA PaCa-2 human pancreatic cancer xenografts in nude mice.
Radulovic S; Nagy A; Szoke B; Schally AV
Cancer Lett; 1992 Mar; 62(3):263-71. PubMed ID: 1317746
[TBL] [Abstract][Full Text] [Related]
37. Immunocytochemical detection of somatostatin receptors sst1, sst2A, sst2B, and sst3 in paraffin-embedded breast cancer tissue using subtype-specific antibodies.
Schulz S; Schulz S; Schmitt J; Wiborny D; Schmidt H; Olbricht S; Weise W; Roessner A; Gramsch C; Höllt V
Clin Cancer Res; 1998 Sep; 4(9):2047-52. PubMed ID: 9748118
[TBL] [Abstract][Full Text] [Related]
38. Octreotide acts as an antitumor angiogenesis compound and suppresses tumor growth in nude mice bearing human hepatocellular carcinoma xenografts.
Jia WD; Xu GL; Xu RN; Sun HC; Wang L; Yu JH; Wang J; Li JS; Zhai ZM; Xue Q
J Cancer Res Clin Oncol; 2003 Jun; 129(6):327-34. PubMed ID: 12811549
[TBL] [Abstract][Full Text] [Related]
39. Characterization of somatostatin receptors on human neuroblastoma tumors.
O'Dorisio MS; Chen F; O'Dorisio TM; Wray D; Qualman SJ
Cell Growth Differ; 1994 Jan; 5(1):1-8. PubMed ID: 8123588
[TBL] [Abstract][Full Text] [Related]
40. Effects of somatostatin and octreotide on the interactions between neoplastic gastroenteropancreatic endocrine cells and endothelial cells: a comparison between in vitro and in vivo properties.
Walter T; Hommell-Fontaine J; Gouysse G; Pourreyron C; Nejjari M; Villaume K; Causeret S; Hervieu V; Poncet G; Roche C; Scoazec JY
Neuroendocrinology; 2011; 94(3):200-8. PubMed ID: 21677423
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
